Best Recall Coverage Structures for CDMOs 2026.

01

First-party dedicated recall policy

Pharmaceutical CDMOs with multi-sponsor MSAs and sterile injectable, biologic, or controlled-substance manufacturing. Most common at $10M+ revenue.

• - Stand-alone recall policy at $3M to $10M first-party limits.
• - Pays the CDMO's own cost of pulling product: notification, retrieval, destruction, replacement product manufacture, lost revenue during the recall window.
• - Triggers on FDA Class I, II, or III recalls; on sponsor-initiated recalls; and on the CDMO's own initiated recalls. Some forms extend to "imminent threat" pre-recall investigation costs.
• - Carrier roster: AIG, Berkshire Hathaway Specialty, Chubb, several Lloyd's syndicates.

Premium range: $25K-$80K annually for a Texas CDMO at $10M-$50M revenue.

02

Products policy sublimit (and why it fails for CDMOs)

CDMOs placed by generalist agents; the default state of most CDMO programs. Functionally non-compliant on most sponsor MSAs.

• - Recall coverage embedded as a sublimit on the products liability policy, typically $100K to $500K.
• - Covers recall execution costs only up to the sublimit; insufficient for a real Class I recall of a sterile injectable or biologic.
• - Sponsor MSAs increasingly require recall as a dedicated line, not as a products sublimit. The sublimit structure is not compliant on strict MSA read.
• - When this is the current state, the gap analysis is mechanical: identify the sponsor MSAs that require dedicated recall, calculate the gap.

Premium range: Effectively included in products premium; structurally inadequate, not a real recommendation.

03

Products-recall combined endorsement (intermediate)

CDMOs whose sponsor MSAs accept recall as an endorsement extension and whose recall exposure is moderate (oral solid dose, low-risk product class).

• - Recall extension endorsement on the products liability policy at $1M to $3M sublimit, named as a dedicated line on the COI.
• - Acceptable to some sponsor MSAs that require "recall coverage" without specifying first-party dedicated form.
• - Less expensive than stand-alone recall but with two structural limits: aggregates with products, and recall response coverage components (PR support, third-party costs) are typically narrower than dedicated form.

Premium range: $5K-$15K annual additional premium on the products policy.

04

Sponsor-funded recall fund

CDMOs whose largest sponsor relationships warrant special-case recall handling; common in M&A-prepped CDMOs and PE-backed platforms.

• - Sponsor MSA includes a recall fund mechanism: the sponsor pre-funds a recall reserve that the CDMO can draw on for sponsor-product recall costs.
• - Sits alongside (not instead of) the CDMO's own recall coverage. Reduces but does not eliminate the CDMO's exposure.
• - Negotiable in long-term sponsor relationships where the CDMO has leverage; routine practice with sponsor relationships exceeding $25M annual revenue.

Premium range: No premium; structural negotiation outcome.

05

Captive-supported recall

CDMOs at $50M+ revenue with consistent claims history and a parent group with multiple operating entities suitable for risk pooling.

• - Recall coverage placed through a captive insurance company owned by the CDMO's parent group, with reinsurance to the commercial market above the captive layer.
• - Premium dollars stay within the parent group; risk is retained at the captive layer and shed to commercial market above.
• - Tax-efficient and capital-efficient at scale; requires meaningful regulatory and governance infrastructure.

Premium range: Captive premium and reinsurance combined typically lower than commercial market at scale, with capital tied up in captive surplus.